AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Report for October

AB Corporate Bond ETF (NASDAQ:EYEG) was the recipient of a significant decrease in short interest in October. As of October 30th, there was short interest totaling 43 shares, a decrease of 95.5% from the October 15th total of 950 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 5,020 shares, the short-interest ratio is presently 0.0 days.

AB Corporate Bond ETF Price Performance

Shares of EYEG stock traded down $0.23 on Tuesday, hitting $33.73. 35 shares of the stock traded hands, compared to its average volume of 542. The firm has a market cap of $26.99 million, a price-to-earnings ratio of -20.08 and a beta of 0.18. AB Corporate Bond ETF has a 52 week low of $33.24 and a 52 week high of $36.46. The firm has a 50 day simple moving average of $33.80 and a two-hundred day simple moving average of $34.87. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.07 and a quick ratio of 3.07.

AB Corporate Bond ETF Increases Dividend

The firm also recently declared a monthly dividend, which was paid on Thursday, November 5th. Shareholders of record on Monday, November 2nd were paid a $0.1460 dividend. This represents a $1.75 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date was Monday, November 2nd. This is a boost from AB Corporate Bond ETF’s previous monthly dividend of $0.1367. AB Corporate Bond ETF’s dividend payout ratio (DPR) is currently -102.38%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.